In vivo versus ex vivo CRISPR therapies for retinal dystrophy

References

• Yanik M, Muller B, Song F, et al. In vivo genome editing as a potential treatment strategy for inherited retinal dystrophies. Prog Retin Eye Res. 2016; doi:10.1016/j.preteyeres.2016.09.001
   PubMedGoogle Scholar
• Bassuk AG, Zheng A, Li Y, et al. Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells. Sci Rep. 2016;6:19969.
   PubMed Web of Science ®Google Scholar
• Yang L, Guell M, Byrne S, et al. Optimization of scarless human stem cell genome editing. Nucleic Acids Res. 2013 Oct;41(19):9049–9061.
   PubMed Web of Science ®Google Scholar
• Cox DB, Platt RJ, Zhang F. Therapeutic genome editing: prospects and challenges. Nat Med. 2015 Feb;21(2):121–131.
   PubMed Web of Science ®Google Scholar
• Mead B, Berry M, Logan A, et al. Stem cell treatment of degenerative eye disease. Stem Cell Res. 2015 May;14(3):243–257.
   PubMed Web of Science ®Google Scholar
• Pearson RA, Gonzalez-Cordero A, West EL, et al. Donor and host photoreceptors engage in material transfer following transplantation of post-mitotic photoreceptor precursors. Nat Commun. 2016 Oct 04;7:13029.
   PubMed Web of Science ®Google Scholar
• Weller SK, Sawitzke JA. Recombination promoted by DNA viruses: phage lambda to herpes simplex virus. Annu Rev Microbiol. 2014;68:237–258.
   PubMed Web of Science ®Google Scholar
• Hung SS, McCaughey T, Swann O, et al. Genome engineering in ophthalmology: application of CRISPR/cas to the treatment of eye disease. Prog Retin Eye Res. 2016;53:1–20.
   PubMed Web of Science ®Google Scholar
• Komor AC, Kim YB, Packer MS, et al. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016 May 19;533(7603):420–424.
   PubMed Web of Science ®Google Scholar
• Bakondi B, Lv W, Lu B, et al. In vivo CRISPR/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa. Mol Ther. 2016 Mar;24(3):556–563.
   PubMed Web of Science ®Google Scholar
• Latella MC, Di Salvo MT, Cocchiarella F, et al. In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations. Mol Ther. 2016;24:S193–S193.
   PubMed Web of Science ®Google Scholar
• Burnight ER, Wiley LA, DeLuca AP, et al. CRISPR/Cas9-mediated genome editing for correction of inherited retinal disease mutations. Invest Ophthalmol Vis Sci. 2016;57(12):1157–1157.
   Google Scholar
• Lewin AS, Dresner KA, Hauswirth WW, et al. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med. 1998 Aug 4;8:967–971.
   Web of Science ®Google Scholar
• LaVail MM, Yasumura D, Matthes MT, et al. Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc Natl Acad Sci. 2000;97(21):11488–11493.
   PubMed Web of Science ®Google Scholar
• Cepko CL, Vandenberghe LH. Retinal gene therapy coming of age. Hum Gene Ther. 2013;24(3):242–244.
   PubMed Web of Science ®Google Scholar
• Koch SF, Tsai Y-T, Duong JK, et al. Halting progressive neurodegeneration in advanced retinitis pigmentosa. J Clin Investig. 2015;125(9):3704–3713.
   PubMed Web of Science ®Google Scholar
• Wu WH, Tsai YT, Justus S, et al. CRISPR repair reveals causative mutation in a preclinical model of retinitis pigmentosa. Mol Ther. 2016 Jun 28;24:1388–1394.
   PubMed Web of Science ®Google Scholar
• Zhong H, Chen Y, Li Y, et al. CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes. Sci Rep. 2015;5:8366.
   PubMed Web of Science ®Google Scholar
• Beryozkin A, Levy G, Blumenfeld A, et al. Genetic analysis of the rhodopsin gene identifies a mosaic dominant retinitis pigmentosa mutation in a healthy individual. Invest Ophthalmol Vis Sci. 2016 Mar;57(3):940–947.
   PubMed Web of Science ®Google Scholar
• Wu Y, Liang D, Wang Y, et al. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell. 2013;13(6):659–662.
   PubMed Web of Science ®Google Scholar
• Perrault I, Delphin N, Hanein S, et al. Spectrum of NPHP6/CEP290 mutations in Leber congenital amaurosis and delineation of the associated phenotype. Hum Mutat. 2007 Apr;28(4):416.
   PubMedGoogle Scholar
• Maeder ML, Mepani R, Gloskowski S, et al. Therapeutic correction of an LCA-causing splice defect in the CEP290 gene by CRISPR/Cas-mediated gene editing. Mol Ther. 2016;24:S51–S52.
   Web of Science ®Google Scholar
• Sharma TP, Giacalone JC, Burnight ER, et al. Human Disease Modeling of TRNT1-Associated Retinitis Pigmentosa In Patient-Derived Cells. Invest Ophthalmol Vis Sci. 2016;57(12):6060–6060.
   Google Scholar
• U.S. Department of Health and Human Services, National Institutes of Health, National Eye Institute. Stone EM. CRISPR/CAS9-Mediated Correction of Mutations that Cause Inherited Retinal Degenerations. Program Number 1R01EY026008-01. 2016.
   Google Scholar
• Wiley LA, Anfinson KR, Cranston C, et al. Genome editing and gene replacement: towards the treatment of Batten disease. Invest phthalmol Vis Sci. 2015;56(7):3593–3593.
   PubMed Web of Science ®Google Scholar
• Yu WH, Mookherjee S, Kim JW, et al. In vivo rod photoreceptor reprogramming using AAV-delivered CRISPR/Cas9 rescues retinal degeneration. Mol Ther. 2016;24:S105–S106.
   Web of Science ®Google Scholar
• Moore R, Spinhirne A, Lai MJ, et al. CRISPR-based self-cleaving mechanism for controllable gene delivery in human cells. Nucleic Acids Res. 2015 Jan;43(2):1297–1303.
   PubMed Web of Science ®Google Scholar
• Zack DJ, Bennett J, Wang Y, et al. Unusual topography of bovine rhodopsin promoter-lacZ fusion gene expression in transgenic mouse retinas. Neuron. 1991 Feb;6(2):187–199.
   PubMed Web of Science ®Google Scholar
• Byrne LC, Dalkara D, Luna G, et al. Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration. J Clin Invest. 2015 Jan;125(1):105–116.
   PubMed Web of Science ®Google Scholar
• Zuris JA, Thompson DB, Shu Y, et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol. 2014;33(1):73–80.
   PubMed Web of Science ®Google Scholar